| Year |
Citation |
Score |
| 2016 |
Fink E, Fuller K, Agan B, Berger EA, Saphire A, Quinnan GV, Elder JH. Humoral antibody responses to HIV viral proteins and to CD4 among HIV controllers, rapid and typical progressors in an HIV positive patient cohort. Aids Research and Human Retroviruses. PMID 27771962 DOI: 10.1089/Aid.2016.0182 |
0.55 |
|
| 2014 |
Quinnan GV, Onabajo O, Zhang P, Yan L, Mattapallil JJ, Zhang Z, Dong M, Lu M, Montefiori D, LaBranche C, Broder CC. Immunization of rabbits with highly purified, soluble, trimeric human immunodeficiency virus type 1 envelope glycoprotein induces a vigorous B cell response and broadly cross-reactive neutralization. Plos One. 9: e98060. PMID 24846288 DOI: 10.1371/Journal.Pone.0098060 |
0.518 |
|
| 2013 |
Quinnan GV, Zhang P, Dong M, Chen H, Feng YR, Lewis M, Broder CC. Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins. Plos One. 8: e59803. PMID 23533650 DOI: 10.1371/Journal.Pone.0059803 |
0.555 |
|
| 2011 |
Celigoy J, Ramirez B, Tao L, Rong L, Yan L, Feng YR, Quinnan GV, Broder CC, Caffrey M. Probing the HIV gp120 envelope glycoprotein conformation by NMR. The Journal of Biological Chemistry. 286: 23975-81. PMID 21592971 DOI: 10.1074/Jbc.M111.251025 |
0.428 |
|
| 2010 |
Chen W, Zhu Z, Liao H, Quinnan GV, Broder CC, Haynes BF, Dimitrov DS. Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins. Viruses. 2: 547-565. PMID 21755021 DOI: 10.3390/V2020547 |
0.576 |
|
| 2010 |
Defang GN, Khetawat D, Broder CC, Quinnan GV. Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system. Vaccine. 29: 212-20. PMID 21050901 DOI: 10.1016/J.Vaccine.2010.10.053 |
0.452 |
|
| 2010 |
Zhang MY, Borges AR, Ptak RG, Wang Y, Dimitrov AS, Alam SM, Wieczorek L, Bouma P, Fouts T, Jiang S, Polonis VR, Haynes BF, Quinnan GV, Montefiori DC, Dimitrov DS. Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1. Mabs. 2: 266-74. PMID 20305395 DOI: 10.4161/Mabs.2.3.11416 |
0.516 |
|
| 2009 |
Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, Ganesan A, Hale B, Crum-Cianflone N, Delmar J, Barthel V, Quinnan G, Agan BK, Dolan MJ. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. The Journal of Infectious Diseases. 200: 1714-23. PMID 19852669 DOI: 10.1086/646609 |
0.357 |
|
| 2008 |
Zhang MY, Vu BK, Choudhary A, Lu H, Humbert M, Ong H, Alam M, Ruprecht RM, Quinnan G, Jiang S, Montefiori DC, Mascola JR, Broder CC, Haynes BF, Dimitrov DS. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens. Journal of Virology. 82: 6869-79. PMID 18480433 DOI: 10.1128/Jvi.00033-08 |
0.572 |
|
| 2007 |
Zhang PF, Cham F, Dong M, Choudhary A, Bouma P, Zhang Z, Shao Y, Feng YR, Wang L, Mathy N, Voss G, Broder CC, Quinnan GV. Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization. Proceedings of the National Academy of Sciences of the United States of America. 104: 10193-8. PMID 17540729 DOI: 10.1073/Pnas.0608635104 |
0.526 |
|
| 2007 |
Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology. 363: 79-90. PMID 17306322 DOI: 10.1016/J.Virol.2007.01.015 |
0.557 |
|
| 2007 |
Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS. Corrigendum to "Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies" [Virology 363 (2007) 79-90] (DOI:10.1016/j.virol.2007.01.015) Virology. 368: 431. DOI: 10.1016/J.Virol.2007.09.004 |
0.535 |
|
| 2006 |
Alarcón JO, Friedman HB, Montano SM, Zunt JR, Holmes KK, Quinnan GV. High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 604-9. PMID 16773029 DOI: 10.1097/01.Qai.0000221680.52563.D5 |
0.309 |
|
| 2006 |
Cham F, Zhang PF, Heyndrickx L, Bouma P, Zhong P, Katinger H, Robinson J, van der Groen G, Quinnan GV. Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity. Virology. 347: 36-51. PMID 16378633 DOI: 10.1016/J.Virol.2005.11.019 |
0.506 |
|
| 2005 |
Quinnan GV, Yu XF, Lewis MG, Zhang PF, Sutter G, Silvera P, Dong M, Choudhary A, Sarkis PT, Bouma P, Zhang Z, Montefiori DC, Vancott TC, Broder CC. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. Journal of Virology. 79: 3358-69. PMID 15731230 DOI: 10.1128/Jvi.79.6.3358-3369.2005 |
0.55 |
|
| 2004 |
Zhang MY, Xiao X, Sidorov IA, Choudhry V, Cham F, Zhang PF, Bouma P, Zwick M, Choudhary A, Montefiori DC, Broder CC, Burton DR, Quinnan GV, Dimitrov DS. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. Journal of Virology. 78: 9233-42. PMID 15308718 DOI: 10.1128/Jvi.78.17.9233-9242.2004 |
0.533 |
|
| 2003 |
Zhang MY, Shu Y, Phogat S, Xiao X, Cham F, Bouma P, Choudhary A, Feng YR, Sanz I, Rybak S, Broder CC, Quinnan GV, Evans T, Dimitrov DS. Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library. Journal of Immunological Methods. 283: 17-25. PMID 14659896 DOI: 10.1016/J.Jim.2003.07.003 |
0.561 |
|
| 2003 |
Bouma P, Leavitt M, Zhang PF, Sidorov IA, Dimitrov DS, Quinnan GV. Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1. Journal of Virology. 77: 8061-71. PMID 12829845 DOI: 10.1128/Jvi.77.14.8061-8071.2003 |
0.481 |
|
| 2003 |
Zwick MB, Kelleher R, Jensen R, Labrijn AF, Wang M, Quinnan GV, Parren PW, Burton DR. A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12. Journal of Virology. 77: 6965-78. PMID 12768015 DOI: 10.1128/Jvi.77.12.6965-6978.2003 |
0.517 |
|
| 2003 |
Dong M, Zhang PF, Grieder F, Lee J, Krishnamurthy G, VanCott T, Broder C, Polonis VR, Yu XF, Shao Y, Faix D, Valente P, Quinnan GV. Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system. Journal of Virology. 77: 3119-30. PMID 12584337 DOI: 10.1128/Jvi.77.5.3119-3130.2003 |
0.558 |
|
| 2003 |
Leavitt M, Park EJ, Sidorov IA, Dimitrov DS, Quinnan GV. Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120. Journal of Virology. 77: 560-70. PMID 12477860 DOI: 10.1128/Jvi.77.1.560-570.2003 |
0.48 |
|
| 2002 |
Zhang PF, Bouma P, Park EJ, Margolick JB, Robinson JE, Zolla-Pazner S, Flora MN, Quinnan GV. A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response. Journal of Virology. 76: 644-55. PMID 11752155 DOI: 10.1128/Jvi.76.2.644-655.2002 |
0.537 |
|
| 2000 |
Park EJ, Gorny MK, Zolla-Pazner S, Quinnan GV. A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex Journal of Virology. 74: 4183-4191. PMID 10756031 DOI: 10.1128/Jvi.74.9.4183-4191.2000 |
0.518 |
|
| 1999 |
Chabot DJ, Zhang PF, Quinnan GV, Broder CC. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. Journal of Virology. 73: 6598-609. PMID 10400757 DOI: 10.1128/Jvi.73.8.6598-6609.1999 |
0.465 |
|
| 1999 |
Park EJ, Quinnan GV. Both neutralization resistance and high infectivity phenotypes are caused by mutations of interacting residues in the human immunodeficiency virus type 1 gp41 leucine zipper and the gp120 receptor- and coreceptor- binding domains Journal of Virology. 73: 5707-5713. PMID 10364321 DOI: 10.1128/Jvi.73.7.5707-5713.1999 |
0.514 |
|
| 1999 |
Zhang PF, Chen X, Fu DW, Margolick JB, Quinnan GV. Primary virus envelope cross-reactivity of the broadening neutralizing antibody response during early chronic human immunodeficiency virus type 1 infection Journal of Virology. 73: 5225-5230. PMID 10233993 DOI: 10.1128/Jvi.73.6.5225-5230.1999 |
0.543 |
|
| 1999 |
Quinnan GV, Zhang PF, Fu DW, Dong M, Alter HJ, Mascola J, Allen S, Ellner J, Nelson K, Sheppard H, Francis G. Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response Aids Research and Human Retroviruses. 15: 561-570. PMID 10221533 DOI: 10.1089/088922299311088 |
0.377 |
|
| 1998 |
Park EJ, Vujcic LK, Anand R, Theodore TS, Quinnan GV. Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes Journal of Virology. 72: 7099-7107. PMID 9696803 DOI: 10.1128/Jvi.72.9.7099-7107.1998 |
0.471 |
|
| 1998 |
Quinnan GV, Zhang PF, Fu DW, Dong M, Margolick JB. Evolution of neutralizing antibody response against HIV type 1 virions and pseudovirions in multicenter AIDS cohort study participants Aids Research and Human Retroviruses. 14: 939-949. PMID 9686640 DOI: 10.1089/Aid.1998.14.939 |
0.502 |
|
| 1997 |
Quinnan GV, Dong M, Zhang PF. Neutralization(Nt) of laboratory and primary (1°) HIV-1 env on pseudoviruses (PV) Clinical Infectious Diseases. 25: 392. |
0.395 |
|
| 1996 |
Gross PA, Denning CR, Gaerlan PF, Bonelli J, Bernius M, Dran S, Monk G, Vassallo M, Quinnan GV, Levandowski R, Cataruozolo PE, Wallenstein S. Annual influenza vaccination: immune response in patients over 10 years. Vaccine. 14: 1280-4. PMID 8961518 DOI: 10.1016/S0264-410X(96)00004-7 |
0.345 |
|
| 1995 |
Vujcic LK, Quinnan GV. Preparation and characterization of human HIV type 1 neutralizing reference sera Aids Research and Human Retroviruses. 11: 783-787. PMID 7546904 |
0.447 |
|
| 1992 |
Sawyer LA, Carrow E, Snoy PJ, Hewlett IK, Quinnan GV, Anand R. Variable infections with and serologic responses of rabbits to five different HIV-1 strains, including one neural tissue isolate Microbios. 71: 243-255. PMID 1479924 |
0.401 |
|
| 1991 |
Hendry RM, Parks DE, Mello DL, Quinnan GV, Castro BG. Lack of evidence for HIV-2 infection among at-risk individuals in Brazil. Journal of Acquired Immune Deficiency Syndromes. 4: 623-7. PMID 2023103 |
0.372 |
|
| 1991 |
Carrow EW, Vujcic LK, Glass WL, Seamon KB, Rastogi SC, Hendry RM, Boulos R, Nzila N, Quinnan GV. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas. Aids Research and Human Retroviruses. 7: 831-8. PMID 1720630 DOI: 10.1089/aid.1991.7.831 |
0.418 |
|
| 1990 |
Katzenstein DA, Vujcic LK, Latif A, Boulos R, Halsey NA, Quinn TC, Rastogi SC, Quinnan GV. Human immunodeficiency virus neutralizing antibodies in sera from north americans and africans Journal of Acquired Immune Deficiency Syndromes. 3: 810-816. PMID 2366149 |
0.468 |
|
| 1989 |
Singer C, Knauert F, Bushar G, Klutch M, Lundquist R, Quinnan GV. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies Journal of Biological Standardization. 17: 137-150. PMID 2541133 DOI: 10.1016/0092-1157(89)90004-8 |
0.329 |
|
| 1988 |
Chen KS, Quinnan GV. Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines Journal of General Virology. 69: 2779-2784. PMID 3183627 |
0.305 |
|
| 1988 |
Shepp DH, Chakrabarti S, Moss B, Quinnan GV. Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus Journal of Infectious Diseases. 157: 1260-1264. PMID 3163712 DOI: 10.1093/Infdis/157.6.1260 |
0.387 |
|
| 1988 |
Vujcic LK, Shepp DH, Klutch M, Wells MA, Hendry RM, Wittek AE, Krilov L, Quinnan GV. Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus. The Journal of Infectious Diseases. 157: 1047-50. PMID 3162928 DOI: 10.1093/infdis/157.5.1047 |
0.354 |
|
| 1988 |
Katzenstein DA, Sawyer LA, Quinnan GV. Issues in the evaluation of AIDS vaccines Aids. 2: 151-155. PMID 3134911 |
0.332 |
|
| 1988 |
Shepp DH, Daguillard F, Mann D, Quinnan GV. Human class 1 MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens Aids. 2: 113-117. PMID 2454643 |
0.413 |
|
| 1988 |
Marcus-Sekura CJ, Woerner AM, Klutch M, Quinnan GV. Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag Bba - Gene Structure and Expression. 949: 213-223. PMID 2449245 DOI: 10.1016/0167-4781(88)90085-1 |
0.41 |
|
| 1987 |
Epstein JS, Grimley PM, Preble O, Fust G, Horvath A, Hollan SR, Pearson GR, Schneider AL, Mayner RE, Phelan MA, Wells MA, Manischewitz JF, Armstrong GR, Varga L, Ujhelyi E, ... Quinnan GV, et al. Absence of Antibodies to Human Immunodeficiency Virus in Homosexual, Hemophiliac, and Heterosexual Men in Budapest, Hungary in 1983-1984 Journal of Infectious Diseases. 155: 134-136. PMID 3025303 DOI: 10.1093/Infdis/155.1.134 |
0.357 |
|
| 1987 |
Wittek AE, Phelan MA, Wells MA, Vujcic LK, Epstein JS, Lane HC, Quinnan GV. Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion Annals of Internal Medicine. 107: 286-292. PMID 2441634 DOI: 10.7326/0003-4819-107-2-286 |
0.364 |
|
| 1986 |
Hendry RM, Wells MA, Phelan MA, Schneider AL, Epstein JS, Quinnan GV. Antibodies to simian immunodeficiency virus in African green monkeys in Africa in 1957-62. Lancet (London, England). 2: 455. PMID 2874433 DOI: 10.1016/S0140-6736(86)92156-2 |
0.374 |
|
| 1983 |
Asano Y, Albrecht P, Vujcic LK, Quinnan GV, Takahashi M. Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test Archives of Virology. 75: 225-228. PMID 6301406 DOI: 10.1007/BF01315277 |
0.331 |
|
| 1982 |
Iltis JP, Castellano GA, Gerber P, Le C, Vujcic LK, Quinnan GV. Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus Journal of Clinical Microbiology. 16: 878-884. PMID 6759530 |
0.359 |
|
| 1980 |
Quinnan GV, Ennis FA, Tuazon CU, Wells MA, Butchko GM, Armstrong R, McLaren C, Manischewitz JF, Kiley S. Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine Infection and Immunity. 30: 362-369. PMID 7439982 |
0.355 |
|
| 1980 |
Manischewitz JE, Quinnan GV. Antivirus antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection Infection and Immunity. 29: 1050-1054. PMID 6253395 |
0.339 |
|
| 1977 |
Echeverria P, Ho MT, Blacklow NR, Quinnan G, Portnoy B, Olson JG, Conklin R, DuPont HL, Cross JH. Relative importance of viruses and bacteria in the etiology of pediatric diarrhea in Taiwan. The Journal of Infectious Diseases. 136: 383-90. PMID 198481 DOI: 10.1093/Infdis/136.3.383 |
0.326 |
|
| Show low-probability matches. |